Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,462 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase 1 Study of JNJ-64619178, a Protein Arginine Methyltransferase 5 Inhibitor, in Advanced Solid Tumors.
Vieito M, Moreno V, Spreafico A, Brana I, Wang JS, Preis M, Hernández T, Genta S, Hansen AR, Doger B, Galvao V, Lenox L, Brown RJ, Kalota A, Mehta J, Pastore F, Patel B, Mistry P, Gu J, Lauring J, Patel MR. Vieito M, et al. Among authors: patel mr, patel b. Clin Cancer Res. 2023 Sep 15;29(18):3592-3602. doi: 10.1158/1078-0432.CCR-23-0092. Clin Cancer Res. 2023. PMID: 37491846 Clinical Trial.
Safety and clinical activity of JNJ-78306358, a human leukocyte antigen-G (HLA-G) x CD3 bispecific antibody, for the treatment of advanced stage solid tumors.
Geva R, Vieito M, Ramon J, Perets R, Pedregal M, Corral E, Doger B, Calvo E, Bardina J, Garralda E, Brown RJ, Greger JG, Wu S, Steinbach D, Yao TS, Cao Y, Lauring J, Chaudhary R, Patel J, Patel B, Moreno V. Geva R, et al. Among authors: patel j, patel b. Cancer Immunol Immunother. 2024 Aug 6;73(10):205. doi: 10.1007/s00262-024-03790-7. Cancer Immunol Immunother. 2024. PMID: 39105878 Free PMC article. Clinical Trial.
Exploration of Immune-Modulatory Effects of Amivantamab in Combination with Pembrolizumab in Lung and Head and Neck Squamous Cell Carcinoma.
Lim SM, Kang SS, Kim DK, Lee SH, Synn CB, Baek S, Yang SM, Han YJ, Kim MH, Han H, Na K, Kim YT, Yun MR, Kim JH, Byeon Y, Kim YS, Lee JB, Hong MH, Curtin JC, Patel B, Bergiers I, Pyo KH, Cho BC. Lim SM, et al. Among authors: patel b. Cancer Res Commun. 2024 Jul 1;4(7):1748-1764. doi: 10.1158/2767-9764.CRC-24-0107. Cancer Res Commun. 2024. PMID: 38916448 Free PMC article.
Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies.
Rubin DT, Allegretti JR, Panés J, Shipitofsky N, Yarandi SS, Huang KG, Germinaro M, Wilson R, Zhang H, Johanns J, Feagan BG, Hisamatsu T, Lichtenstein GR, Bressler B, Peyrin-Biroulet L, Sands BE, Dignass A; QUASAR Study Group. Rubin DT, et al. Lancet. 2024 Dec 17:S0140-6736(24)01927-5. doi: 10.1016/S0140-6736(24)01927-5. Online ahead of print. Lancet. 2024. PMID: 39706209
The microbiome and the eye: a new era in ophthalmology.
Kaur S, Patel BCK, Collen A, Malhotra R. Kaur S, et al. Among authors: patel bck. Eye (Lond). 2024 Dec 19. doi: 10.1038/s41433-024-03517-z. Online ahead of print. Eye (Lond). 2024. PMID: 39702789 Review.
Primate Phenotypes: A Multi-Institution Collection of 3D Morphological Data Housed in MorphoSource.
Almécija S, Pugh KD, Anaya A, Smith CM, Simmons NB, Voss RS, Duncan N, Lunde DP, Viera MK, Hsu T, Gilissen E, Maiolino SA, Winchester JM, Patel BA, Orr CM, Tocheri MW, Delson E, Hammond AS, Boyer DM, Catalano SA. Almécija S, et al. Among authors: patel ba. Sci Data. 2024 Dec 18;11(1):1391. doi: 10.1038/s41597-024-04261-5. Sci Data. 2024. PMID: 39695181 Free PMC article.
Primary Gliosarcoma: A 15-Year Experience at a Tertiary Care Center.
Nayak R, Akash J, Patel B, Gandham EJ, Krishnaprabhu R. Nayak R, et al. Among authors: patel b. Neurol India. 2024 Nov 1;72(6):1213-1217. doi: 10.4103/neurol-india.Neurol-India-D-24-00804. Epub 2024 Dec 17. Neurol India. 2024. PMID: 39690994 Free article.
Association of Lung Immune Prognostic Index (LIPI) with Disease Control Rate and Progression-Free Survival in Patients with Soft-Tissue Sarcoma Treated with Immunotherapy in Early-Phase Trials.
Zoghbi M, Patel BA, Roulleaux Dugage M, Mezquita L, Bahleda R, Dufresne A, Brahmi M, Ray-Coquard I, Pautier P, Blay JY, Le Cesne A, Massard C, Besse B, Auclin E, Nassif Haddad EF. Zoghbi M, et al. Among authors: patel ba. Cancers (Basel). 2024 Dec 3;16(23):4053. doi: 10.3390/cancers16234053. Cancers (Basel). 2024. PMID: 39682239 Free PMC article.
4,462 results